NCT06195904View on ClinicalTrials.gov

Genomic Profiling of Pancreatic Cystic Tumors

Not yet recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

May 15, 2028

Study Completion Date

May 15, 2030

Conditions
Pancreatic Cyst
Interventions
OTHER

NA (No intervention)

NA (No intervention)

Trial Locations (2)

06351

Samsung Medical Center, Seoul

06591

Seoul St. Mary's Hospital, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT06195904 - Genomic Profiling of Pancreatic Cystic Tumors | Biotech Hunter | Biotech Hunter